| TAMeless traitors: macrophages in cancer progression and metastasis S Aras, MR Zaidi British journal of cancer 117 (11), 1583-1591, 2017 | 583 | 2017 |
| CDK7 inhibition suppresses castration-resistant prostate cancer through MED1 inactivation R Rasool, R Natesan, Q Deng, S Aras, P Lal, S Sander Effron, ... Cancer discovery 9 (11), 1538-1555, 2019 | 92 | 2019 |
| BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation HG Marathe, DE Watkins-Chow, M Weider, A Hoffmann, G Mehta, ... Nucleic acids research 45 (11), 6442-6458, 2017 | 64 | 2017 |
| BRG 1 promotes survival of UV‐irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene SV Saladi, PG Wong, AR Trivedi, HG Marathe, B Keenen, S Aras, ZQ Liew, ... Pigment cell & melanoma research 26 (3), 377-391, 2013 | 49 | 2013 |
| RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration I Datar, X Qiu, HZ Ma, M Yeung, S Aras, I de la Serna, F Al-Mulla, ... Oncotarget 6 (36), 39050, 2015 | 48 | 2015 |
| RKIP inhibits local breast cancer invasion by antagonizing the transcriptional activation of MMP13 I Datar, J Feng, X Qiu, J Lewandowski, M Yeung, G Ren, S Aras, ... PloS one 10 (8), e0134494, 2015 | 36 | 2015 |
| SWI/SNF chromatin remodeling enzymes in melanocyte differentiation and melanoma A Mehrotra, G Mehta, S Aras, A Trivedi, I de la Serna Critical Reviews™ in Eukaryotic Gene Expression 24 (2), 2014 | 32 | 2014 |
| BAF60A mediates interactions between the microphthalmia‐associated transcription factor and the BRG1‐containing SWI/SNF complex during melanocyte differentiation S Aras, SV Saladi, T Basuroy, HG Marathe, P Lorès, IL de la Serna Journal of Cellular Physiology 234 (7), 11780-11791, 2019 | 14 | 2019 |
| Epigenetic regulation of chromatin in prostate cancer R Natesan, S Aras, SS Effron, IA Asangani Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and …, 2019 | 10 | 2019 |
| CDK7 inhibition suppresses castration-resistant prostate cancer through MED1 inactivation. Cancer Discov. 2019; 9: 1538–1555. doi: 10.1158/2159-8290 RU Rasool, R Natesan, Q Deng, S Aras, P Lal, SS Effron, ... CD-19-0189.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 8 | |
| Spatiotemporal labeling of melanocytes in mice S Preston, S Aras, MR Zaidi International Journal of Molecular Sciences 19 (5), 1469, 2018 | 6 | 2018 |
| Modulation of BRAHMA expression by the mitogen-activated protein kinase/extracellular signal regulated kinase pathway is associated with changes in melanoma proliferation A Mehrotra, SV Saladi, AR Trivedi, S Aras, H Qi, A Jayanthy, V Setaluri, ... Archives of biochemistry and biophysics 563, 125-135, 2014 | 4 | 2014 |
| Correction: RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration I Datar, X Qiu, HZ Ma, M Yeung, S Aras, I De La Serna, F Al-Mulla, ... Oncotarget 7 (18), 26925, 2016 | 3 | 2016 |
| Adeno-associated virus-mediated trastuzumab delivery to the central nervous system for human epidermal growth factor receptor 2+ brain metastasis MS Werner, S Aras, AR Morgan, J Roamer, NJ Param, K Olagbegi, ... Cancer Gene Therapy, 1-12, 2024 | | 2024 |
| NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis A Parolia, S Eyunni, BK Verma, E Young, L Liu, J George, S Aras, CK Das, ... bioRxiv, 2024 | | 2024 |
| Optimizing adeno-associated viral vector-mediated delivery of trastuzumab to the central nervous system for the treatment of Her2 positive brain metastasis. MS Werner, S Aras, A Morgan, NJ Param, J Greig, JM Wilson CANCER RESEARCH 82 (12), 2022 | | 2022 |
| Abstract LB201: Optimizing adeno-associated viral vector-mediated delivery of trastuzumab to the central nervous system for the treatment of Her2 positive brain metastasis MS Werner, S Aras, A Morgan, NJ Param, J Greig, JM Wilson Cancer Research 82 (12_Supplement), LB201-LB201, 2022 | | 2022 |
| Targeting transcriptional addiction in anti-androgen refractory castration-resistant prostate cancer R Rasool, R Natesan, Q Deng, S Aras, SS Effron, SS Effron, ... Cancer Research 80 (16_Supplement), 1262-1262, 2020 | | 2020 |
